Find out the latest with BOPA, Oncology, and upcoming events
17th December 2025 13:00-14:00 GMT REGISTER for the Webinar HERE Available for both PAID members and FREE associates The BOPA Education and Training Subcommittee would like to invite you to one…
The popular Introduction to Cancer Course is coming to to Glasgow in March 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 26th & Friday 27th March 2026 WHERE: The…
The 2026 PRUK funding round launched on 24th November 2025 and will close at 1pm on 25th March 2026. BOPA-PRUK Research Award – NOW OPEN for Applications 2026 This award provides pharmacy professionals…
The Research Subcommittee would like to invite members to participate in this MPharm research project. Please find further details below. I am a 4th year pharmacy student at Kingston University…
Dear Colleagues, The University of Birmingham and University Hospitals Birmingham are jointly conducting a project exploring staff perceptions around the challenges of implementing NICE Technology Appraisal Guidance (TAGs) in Cancer Services. We…
Back again by Popular Demand – SAVE THE DATE Pharmacist Essential Guide to Haematology Delivered by UCLH Cancer Academy 16th and 17th March 2026 @ UCLH Education centre Are you…
The popular Introduction to Cancer Course is coming to to Glasgow in March 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 26th & Friday 27th March 2026 WHERE: The…
BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…
The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…
With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…
IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…
The BOPA Immunotherapy Cancer Advisory Group, have recently done some research into immune-related cardiac toxicity; both the monitoring for, and management of, these rare but serious adverse effects. Simon Jenkinson,…
